154 related articles for article (PubMed ID: 9627671)
1. Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series.
Etievant C; Schambel P; Guminski Y; Barret JM; Imbert T; Hill BT
Anticancer Drug Des; 1998 Jun; 13(4):317-36. PubMed ID: 9627671
[TBL] [Abstract][Full Text] [Related]
2. Comparative cytotoxicities of a series of ellipticine and olivacine derivatives on multidrug resistant cells of human and murine origins.
Chevallier-Multon MC; Jacquemin-Sablon A; Besselièvre R; Husson HP; Le Pecq JB
Anticancer Drug Des; 1990 Nov; 5(4):319-35. PubMed ID: 1981310
[TBL] [Abstract][Full Text] [Related]
3. [A multivariate analysis approach to antineoplastic and antiviral structure-activity relationships to a series of podophyllotoxins].
Doré JC; Viel C; Pageot N; Gordaliza M; Castro A; del Corral JM; Feliciano AS
J Pharm Belg; 1996; 51(1):9-18. PubMed ID: 8882445
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and activities of 4-deoxy-4 beta-arylmehtylene sulfonylamido-4'-demethylpodophyllotoxins].
He Y; Ma WY; Chen XH; Zhang CN
Yao Xue Xue Bao; 2001 Feb; 36(2):105-7. PubMed ID: 12579874
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis of spin labeled analogue of podophyllotoxin glycoside].
Lu K; Chen Y
Yao Xue Xue Bao; 1998 Dec; 33(12):948-50. PubMed ID: 12016863
[TBL] [Abstract][Full Text] [Related]
6. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues.
Gupta RS
Cancer Res; 1983 Feb; 43(2):505-12. PubMed ID: 6848174
[TBL] [Abstract][Full Text] [Related]
7. Induction of P-glycoprotein functional activity and multidrug resistance by a soluble factor(s) produced by some mammalian cells.
Eliseenkova AV; Ktitorova OV; Kakpakova ES; Sidorova TA; Stavrovskaya AA
Membr Cell Biol; 1998; 12(4):469-79. PubMed ID: 10367565
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
[TBL] [Abstract][Full Text] [Related]
9. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs.
Kelleher JK
Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611.
Daley L; Guminski Y; Demerseman P; Kruczynski A; Etiévant C; Imbert T; Hill BT; Monneret C
J Med Chem; 1998 Nov; 41(23):4475-85. PubMed ID: 9804687
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells.
Guo YE; Chen H; Zuo S; Liu DL; Lu YL; Lv JJ; Wen SP; Zhang TC
J Asian Nat Prod Res; 2011 May; 13(5):417-24. PubMed ID: 21534039
[TBL] [Abstract][Full Text] [Related]
12. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB
Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171
[TBL] [Abstract][Full Text] [Related]
14. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
[TBL] [Abstract][Full Text] [Related]
16. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.
Desbène S; Giorgi-Renault S
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D
J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135
[TBL] [Abstract][Full Text] [Related]
19. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity.
Alam MA; Naik PK
J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and antitumor activities of 4-acylamido-4-deoxy-4'-demethylepipodophyllotoxin analogues].
Wang ZG; Yin SF; Ma WY; Li BS; Zhang CN
Yao Xue Xue Bao; 1993; 28(6):422-7. PubMed ID: 8249599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
